HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral flecainide is effective in management of refractory tachycardia in infants.

AbstractBACKGROUND:
Propranolol and digoxin have been used as first line drugs for treatment of supraventricular tachycardia (SVT) in infants. Flecainide and other drugs have been effective as a second line treatment for controlling refractory SVT.
MATERIAL AND METHODS:
This is a prospective study without randomization and control. The inclusion criteria were: infants (≤12 months) with tachyarrhythmia who failed to respond to first line drugs. Patients having post-surgical arrhythmias were excluded from the study.
RESULTS:
A total of 8 infants were treated with flecainide for refractory tachyarrhythmia's. Diagnosis on electrocardiogram (ECG) was atrioventricular reentry tachycardia (AVRT) in 5, atrial ectopic tachycardia (AET) in 2, a combination of AVRT and atrioventricular nodal reentry tachycardia (AVNRT) in 1. All patients had failed trial of antiarrhythmic drugs prior to presentation: digoxin and propranolol in 7, amiodarone in 3, cardioversion in 1. Flecainide (80-130 mg/m(2) orally) resulted in termination of the tachycardia in all 8 patients. Acute pharmacological termination of arrhythmia occurred with oral flecainide loading in 1 and temporarily with intravenous esmolol loading in 1 patient. Adjuvant therapy in form of propranolol was used in 5 and digoxin in 2. There were no side effects noted. Four episodes of recurrence were noted in 3 patients over 2 years, all of which responded to dose increase. Mean follow up time is 24.75 months.
CONCLUSION:
This small case series indicates that flecainide is an effective antiarrhythmic agent, free of side effects and when used orally is capable of terminating and controlling relatively resistant supraventricular tachycardia in children.
AuthorsVikas Kohli
JournalIndian heart journal (Indian Heart J) 2013 Mar-Apr Vol. 65 Issue 2 Pg. 168-71 ISSN: 0019-4832 [Print] India
PMID23647896 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Arrhythmia Agents
  • Flecainide
Topics
  • Administration, Oral
  • Anti-Arrhythmia Agents (therapeutic use)
  • Flecainide (therapeutic use)
  • Humans
  • Infant
  • Prospective Studies
  • Tachycardia, Atrioventricular Nodal Reentry (drug therapy)
  • Tachycardia, Ectopic Atrial (drug therapy)
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: